HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis
Spondyloarthritis (SpA) is a group of inflammatory rheumatic diseases characterized by common clinical features, such as inflammatory enthesitis, arthritis and/or back pain. SpA is strongly associated with human leukocyte antigen (HLA) class I allotype B27. Ankylosing spondylitis has historically be...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/14/3006 |
id |
doaj-cb8b788e7dfa4af298b99f8c5973fe3d |
---|---|
record_format |
Article |
spelling |
doaj-cb8b788e7dfa4af298b99f8c5973fe3d2021-07-23T13:47:44ZengMDPI AGJournal of Clinical Medicine2077-03832021-07-01103006300610.3390/jcm10143006HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated SpondyloarthritisElvira Favoino0Livio Urso1Alessandra Serafino2Francesca Misceo3Giacomo Catacchio4Marcella Prete5Federico Perosa6Department of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, ItalyDepartment of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, ItalyDepartment of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, ItalyDepartment of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, ItalyDepartment of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, ItalyDepartment of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, ItalyDepartment of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, ItalySpondyloarthritis (SpA) is a group of inflammatory rheumatic diseases characterized by common clinical features, such as inflammatory enthesitis, arthritis and/or back pain. SpA is strongly associated with human leukocyte antigen (HLA) class I allotype B27. Ankylosing spondylitis has historically been the SpA subgroup with one of the strongest, best-proven associations with HLA-B27. The remaining SpA subgroups, namely psoriatic arthritis (PsA), inflammatory bowel diseases-associated arthritis/spondylitis, reactive arthritis, and undifferentiated SpA (uSpA), have also been associated with HLA allotypes other than HLA-B27. In this retrospective study, we analyzed the association between the HLA class I and II haplotypes and the susceptibility to enthesitis and/or arthritis (E/A). Special attention was paid to E/A responding to disease-modifying antirheumatic drugs (DMARDs) not fulfilling ASAS classification criteria (ASAS<sup>−</sup>), as compared to ASAS<sup>+</sup> forms including PsA and uSpA. The whole E/A group showed significant independent associations with HLA-A28(68), B27, Cw3, Cw12, and DQ1; taken singly, PsA was associated with HLA-B27 and DQ1, uSpA with HLA-B16(38,39) and B27, and E/A ASAS<sup>−</sup> with HLA-A28(68), Cw8, and Cw12. This study identified novel risk HLA allotypes for different SpA subgroups in an Italian population. HLA typing could aid the diagnosis and treatment of E/A subgroups, including DMARDS-responsive forms not fulfilling ASAS classification criteria.https://www.mdpi.com/2077-0383/10/14/3006spondyloarthritishuman leukocyte antigenundifferentiated enthesitis and/or arthritisASAS classification criteriaclinical management |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Elvira Favoino Livio Urso Alessandra Serafino Francesca Misceo Giacomo Catacchio Marcella Prete Federico Perosa |
spellingShingle |
Elvira Favoino Livio Urso Alessandra Serafino Francesca Misceo Giacomo Catacchio Marcella Prete Federico Perosa HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis Journal of Clinical Medicine spondyloarthritis human leukocyte antigen undifferentiated enthesitis and/or arthritis ASAS classification criteria clinical management |
author_facet |
Elvira Favoino Livio Urso Alessandra Serafino Francesca Misceo Giacomo Catacchio Marcella Prete Federico Perosa |
author_sort |
Elvira Favoino |
title |
HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis |
title_short |
HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis |
title_full |
HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis |
title_fullStr |
HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis |
title_full_unstemmed |
HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis |
title_sort |
hla allele prevalence in disease-modifying antirheumatic drugs-responsive enthesitis and/or arthritis not fulfilling asas criteria: comparison with psoriatic and undifferentiated spondyloarthritis |
publisher |
MDPI AG |
series |
Journal of Clinical Medicine |
issn |
2077-0383 |
publishDate |
2021-07-01 |
description |
Spondyloarthritis (SpA) is a group of inflammatory rheumatic diseases characterized by common clinical features, such as inflammatory enthesitis, arthritis and/or back pain. SpA is strongly associated with human leukocyte antigen (HLA) class I allotype B27. Ankylosing spondylitis has historically been the SpA subgroup with one of the strongest, best-proven associations with HLA-B27. The remaining SpA subgroups, namely psoriatic arthritis (PsA), inflammatory bowel diseases-associated arthritis/spondylitis, reactive arthritis, and undifferentiated SpA (uSpA), have also been associated with HLA allotypes other than HLA-B27. In this retrospective study, we analyzed the association between the HLA class I and II haplotypes and the susceptibility to enthesitis and/or arthritis (E/A). Special attention was paid to E/A responding to disease-modifying antirheumatic drugs (DMARDs) not fulfilling ASAS classification criteria (ASAS<sup>−</sup>), as compared to ASAS<sup>+</sup> forms including PsA and uSpA. The whole E/A group showed significant independent associations with HLA-A28(68), B27, Cw3, Cw12, and DQ1; taken singly, PsA was associated with HLA-B27 and DQ1, uSpA with HLA-B16(38,39) and B27, and E/A ASAS<sup>−</sup> with HLA-A28(68), Cw8, and Cw12. This study identified novel risk HLA allotypes for different SpA subgroups in an Italian population. HLA typing could aid the diagnosis and treatment of E/A subgroups, including DMARDS-responsive forms not fulfilling ASAS classification criteria. |
topic |
spondyloarthritis human leukocyte antigen undifferentiated enthesitis and/or arthritis ASAS classification criteria clinical management |
url |
https://www.mdpi.com/2077-0383/10/14/3006 |
work_keys_str_mv |
AT elvirafavoino hlaalleleprevalenceindiseasemodifyingantirheumaticdrugsresponsiveenthesitisandorarthritisnotfulfillingasascriteriacomparisonwithpsoriaticandundifferentiatedspondyloarthritis AT liviourso hlaalleleprevalenceindiseasemodifyingantirheumaticdrugsresponsiveenthesitisandorarthritisnotfulfillingasascriteriacomparisonwithpsoriaticandundifferentiatedspondyloarthritis AT alessandraserafino hlaalleleprevalenceindiseasemodifyingantirheumaticdrugsresponsiveenthesitisandorarthritisnotfulfillingasascriteriacomparisonwithpsoriaticandundifferentiatedspondyloarthritis AT francescamisceo hlaalleleprevalenceindiseasemodifyingantirheumaticdrugsresponsiveenthesitisandorarthritisnotfulfillingasascriteriacomparisonwithpsoriaticandundifferentiatedspondyloarthritis AT giacomocatacchio hlaalleleprevalenceindiseasemodifyingantirheumaticdrugsresponsiveenthesitisandorarthritisnotfulfillingasascriteriacomparisonwithpsoriaticandundifferentiatedspondyloarthritis AT marcellaprete hlaalleleprevalenceindiseasemodifyingantirheumaticdrugsresponsiveenthesitisandorarthritisnotfulfillingasascriteriacomparisonwithpsoriaticandundifferentiatedspondyloarthritis AT federicoperosa hlaalleleprevalenceindiseasemodifyingantirheumaticdrugsresponsiveenthesitisandorarthritisnotfulfillingasascriteriacomparisonwithpsoriaticandundifferentiatedspondyloarthritis |
_version_ |
1721287714737750016 |